These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 32538061)
1. Peripheral Blood miR-148 Serves as a Novel Biomarker in Ulcerative Colitis Patients. Ji Q; Li Y Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538061 [TBL] [Abstract][Full Text] [Related]
2. Correlations between the serum bilirubin level and ulcerative colitis: a case-control study. Shi H; Feng Y; Jiang J; Zhao J; Li X; Liu X Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):992-997. PubMed ID: 31205128 [TBL] [Abstract][Full Text] [Related]
3. [Comparative usefulness of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of ulcerative colitis]. Ha JS; Lee JS; Kim HJ; Moon TG; Chang DK; Lee JH; Kim YH; Rhee PL; Kim JJ; Rhee JC Korean J Gastroenterol; 2006 Nov; 48(5):313-20. PubMed ID: 17132919 [TBL] [Abstract][Full Text] [Related]
4. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients. Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597 [TBL] [Abstract][Full Text] [Related]
6. Red cell distribution width for assessment of activity of inflammatory bowel disease. Cakal B; Akoz AG; Ustundag Y; Yalinkilic M; Ulker A; Ankarali H Dig Dis Sci; 2009 Apr; 54(4):842-7. PubMed ID: 18716874 [TBL] [Abstract][Full Text] [Related]
7. Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease. Wang H; Zhang S; Yu Q; Yang G; Guo J; Li M; Zeng Z; He Y; Chen B; Chen M Medicine (Baltimore); 2016 Feb; 95(5):e2703. PubMed ID: 26844512 [TBL] [Abstract][Full Text] [Related]
8. Correlations of C-reactive protein levels and erythrocyte sedimentation rates with endoscopic activity indices in patients with ulcerative colitis. Yoon JY; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH Dig Dis Sci; 2014 Apr; 59(4):829-37. PubMed ID: 24352705 [TBL] [Abstract][Full Text] [Related]
9. Correlation of Blood and Intestinal Mucosa miR-34a Expressions with Disease Severity in Ulcerative Colitis Patients. Li YL; Cai CQ; Shi XL; Xu XF; Guo LJ Clin Lab; 2024 May; 70(5):. PubMed ID: 38747908 [TBL] [Abstract][Full Text] [Related]
10. Assessment of Circulating MicroRNAs for the Diagnosis and Disease Activity Evaluation in Patients with Ulcerative Colitis by Using the Nanostring Technology. Polytarchou C; Oikonomopoulos A; Mahurkar S; Touroutoglou A; Koukos G; Hommes DW; Iliopoulos D Inflamm Bowel Dis; 2015 Nov; 21(11):2533-9. PubMed ID: 26313695 [TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of circulating midkine in ulcerative colitis. Krzystek-Korpacka M; Neubauer K; Matusiewicz M Clin Chem Lab Med; 2009; 47(9):1085-90. PubMed ID: 19728850 [TBL] [Abstract][Full Text] [Related]
12. [Method of diagnosis of the severity of the disease attack in patients with ulcerative colitis.]. Tretyakova YI; Bulatova IA; Shchekotova AP; Sheludko VS Klin Lab Diagn; 2018; 63(7):414-418. PubMed ID: 30720956 [TBL] [Abstract][Full Text] [Related]
13. Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patients. Xie Y; Zhuang T; Ping Y; Zhang Y; Wang X; Yu P; Duan X Clin Chim Acta; 2021 Jun; 517():122-126. PubMed ID: 33662359 [TBL] [Abstract][Full Text] [Related]
14. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis. Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909 [TBL] [Abstract][Full Text] [Related]
15. Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis. Soendergaard C; Nielsen OH; Seidelin JB; Kvist PH; Bjerrum JT Inflamm Bowel Dis; 2015 May; 21(5):1077-88. PubMed ID: 25803506 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E-major urinary metabolite as a reliable surrogate marker for mucosal inflammation in ulcerative colitis. Arai Y; Arihiro S; Matsuura T; Kato T; Matsuoka M; Saruta M; Mitsunaga M; Matsuura M; Fujiwara M; Okayasu I; Ito S; Tajiri H Inflamm Bowel Dis; 2014 Jul; 20(7):1208-16. PubMed ID: 24846719 [TBL] [Abstract][Full Text] [Related]
17. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. Xiang JY; Ouyang Q; Li GD; Xiao NP World J Gastroenterol; 2008 Jan; 14(1):53-7. PubMed ID: 18176961 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Serum Total Bilirubin in Predicting the Severity of Ulcerative Colitis: A Cross-Sectional Study. Zhang MH; Wang HG; Shi YT; Zhou JF; Yan W; Ma TH; Wu SN; Yang XZ Ann Clin Lab Sci; 2020 Mar; 50(2):228-232. PubMed ID: 32366561 [TBL] [Abstract][Full Text] [Related]
19. Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis. Wang Y; Ren R; Sun G; Peng L; Tian Y; Yang Y Int Immunopharmacol; 2020 Aug; 85():106661. PubMed ID: 32563025 [TBL] [Abstract][Full Text] [Related]
20. Serum miR-599 Serves as a Biomarker for Ischemic Stroke Patients. Sun X; Lv J; Chen D; Hu X Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]